巨噬细胞功能和炎症消退机制及与牙周炎关系研究进展

doi:10.7518/hxkq.2017.04.016

摘要/Abstract

摘要：

巨噬细胞是人体固有免疫系统中重要的组成部分,具有强大的识别、吞噬、清除细菌及外来异物的功能。牙周炎是一种以牙龈炎症和牙槽骨丧失为特征的慢性感染性疾病,是成年人失牙的主要病因。目前已经明确,牙周炎的组织破坏是由宿主对感染的免疫应答引起的,巨噬细胞作为宿主免疫应答的重要组成部分,在炎症的发生发展中起重要作用。近年研究显示,巨噬细胞在炎症消退过程中亦扮演着重要作用。本文就巨噬细胞在炎症的发生、发展及消退中的作用进行综述,并总结了其在牙周炎发展及治疗中可能的作用。

关键词: 巨噬细胞, 牙周炎, 极化, 胞葬, 促炎消散介质, 脂氧素

Abstract:

Macrophage plays an important role in human innate immune system. It has powerful functions, such as recog-nition, phagocytosis, and bacteria and foreign body removal. Periodontitis, which is a chronic infectious disease characterized by gum inflammation and bone loss, is a major cause of tooth loss in adults. Several studies demonstrated that periodontal tissue destruction is caused by the host immune response defending against infections. As an important part of host immune response, macrophage is also involved in periodontitis pathogenesis. Recently, anti-inflammatory and proresolving activities of macrophage was discovered. Thus, the complex function of macrophage in the occurrence, development, and resolution of inflammation and its potential role in periodontitis were reviewed.

Key words: macrophage, periodontitis, polarization, efferocytosis, proresolving mediators, lipoxin

中图分类号:

R780.2

白林, 辛月娇, 段丁瑜, 徐屹. 巨噬细胞功能和炎症消退机制及与牙周炎关系研究进展[J]. 华西口腔医学杂志, 2017, 35(4): 427-432.

Lin Bai, Yuejiao Xin, Dingyu Duan, Yi Xu. Advances in macrophage function and its anti-inflammatory and proresolving activity and role in periodontitis deve-lopment[J]. West China Journal of Stomatology, 2017, 35(4): 427-432.

参考文献 52

[1]	金伯泉. 医学免疫学[M]. 5版. 北京: 人民卫生出版社, 2011:136-139.
	Jin BQ.Medical immunology[M]. 5th ed. Beijing: People’s Medical Publishing House, 2001:136-139.
[2]	Cavaillon JM.The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff[J]. J Leu-koc Biol, 2011, 90(3):413-424.
[3]	Mackaness GB.Cellular resistance to infection[J]. J Exp Med, 1962, 116:381-406.
[4]	van Furth R, Cohn ZA, Hirsch JG, et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells[J]. Bull World Health Organ, 1972, 46(6):845-852.
[5]	Orkin SH, Zon LI.Hematopoiesis: an evolving paradigm for stem cell biology[J]. Cell, 2008, 132(4):631-644.
[6]	Stephen J, David A.Homeostasis in the mononuclear pha-gocyte system[J]. Trends Immunol, 2014, 35(8):358-367.
[7]	Gordon S, Taylor PR.Monocyte and macrophage heteroge-neity[J]. Nat Rev Immunol, 2005, 5(12):953-964.
[8]	Gordon S.Alternative activation of macrophages[J]. Nat Rev Immunol, 2003, 3(1):23-35.
[9]	Martinez FO, Sica A, Mantovani A, et al.Macrophage acti-vation and polarization[J]. Front Biosci, 2008, 13(1):453-461.
[10]	Sima C, Glogauer M.Macrophage subsets and osteoimmu-nology: tuning of the immunological recognition and effec-tor systems that maintain alveolar bone[J]. Periodontology 2000, 2013, 63(1):80-101.
[11]	Italiani P, Borasch D.From monocytes to M1/M2 macro-phages: phenotypical vs.functional differentiation[J]. Front Immunol, 2014, 5:514.
[12]	Chang MK, Raggatt LJ, Alexander KA, et al.Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo[J]. J Immunol, 2008, 181(2):1232-1244.
[13]	Alexander KA, Chang MK, Maylin ER, et al.Osteal macro-phages promote in vivo intramembranous bone healing in a mouse tibial injury mode[J]. J Bone Miner Res, 2011, 26(7):1517-1532.
[14]	Wilson HM.SOCS proteins in macrophage polarization and function[J]. Front Immunol, 2014, 5:357.
[15]	Bashir S, Sharma Y, Elahi A, et al.Macrophage polariza-tion: the link between inflammation and related diseases[J]. Inflamm Res, 2016, 65(1):1-11.
[16]	Grimm MC, Pullman WE, Bennett GM, et al.Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa[J]. J Gastroenterol Hepatol, 1995, 10(4):387-395.
[17]	Kobayashi SD, Voyich JM, Burlak C, et al.Neutrophils in the innate immune response[J]. Arch Immunol Ther Exp (Warsz), 2005, 53(6):505-517.
[18]	Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte[J]. Cell, 2005, 123(2):321-334.
[19]	Martin CJ, Peters KN, Behar SM.Macrophages clean up: efferocytosis and microbial control[J]. Curr Opin in Micro-biol, 2014, 17(1):17-23.
[20]	Korns D, Frasch SC, Fernandez-Boyanapalli R, et al.Modu-lation of macrophage efferocytosis in inflammation[J]. Front Immunol, 2011, 2:57.
[21]	Fadok VA, Bratton DL, Henson PM.Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences[J]. J Clin Invest, 2001, 108(7):957-962.
[22]	Kinchen JM, Ravichandran KS.Phagosome maturation: going through the acid test[J]. Nat Rev Mol Cell Biol, 2008, 9(10):781-795.
[23]	Osadal Y, Sunatanil T, Kim IS, et al.Signalling pathway involving GULP, MAPK and Rac1 for SR-BI-induced pha-gocytosis of apoptotic cells[J]. J Biochem, 2009, 145(3):387-394.
[24]	Kimura T, Kobayashi S, Hanihara-Tatsuzawa F, et al.Res-ponses of macrophages to the danger signals released from necrotic cells[J]. Int Immunol, 2014, 26(12):697-704.
[25]	Schif-Zuck S, Gross N, Assi S, et al.Satiated-efferocytosis generates pro-resolving CD11blow macrophages: modulation by resolvins and glucocorticoids[J]. Eur J Immunol, 2011, 41(2):366-379.
[26]	Serhan CN.Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution[J]. Prostaglandins Leukot Essent Fatty Acids, 2005, 73(3/4):141-162.
[27]	Maderna P, Cottell DC, Berlasconi G, et al.Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases[J]. Am J Pathol, 2002, 160(6):2275-2283.
[28]	Godson C, Mitchell S, Harvey K, et al.Cutting edge: lipo-xins rapidly stimulate nonphlogistic phagocytosis of apop-totic neutrophils by monocyte-derived macrophages[J]. J Immunol, 2000, 164(4):1663-1667.
[29]	Freire-de-Lima CG, Xiao YQ, Gardai SJ, et al. Apoptotic cells, through transforming growth factor-β, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages[J]. J Biol Chem, 2006, 281(50):38376-38384.
[30]	Serhan CN, Yang R, Martinod K, et al.Maresins: novel macrophage mediators with potent anti-inflammatory and proresolving actions[J]. J Exp Med, 2009, 206(1):15-23.
[31]	Deng B, Wang CW, Arnardottir HH, et al.Maresin biosyn-thesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages[J]. PLoS One, 2014, 9(7):e102362.
[32]	Abdulnour RE, Dalli J, Colby JK, et al.Maresin 1 biosynthe-sis during platelet-neutrophil interactions is organ-protective[J]. Proc Natl Acad Sci U S A, 2014, 111(46):16526-16531.
[33]	Nordgren TM, Bauer CD, Heires AJ, et al.Maresin-1 reduces airway inflammation associated with acute and repetitive exposures to organic dust[J]. Transl Res, 2015, 166(1):57-69.
[34]	Serhan CN, Dalli J, Karamnov S, et al.Macrophage pro-resolving mediator maresin 1 stimulates tissue regeneration and controls pain[J]. FASEB J, 2012, 26(4):1755-1765.
[35]	Gong J, Liu H, Wu J, et al.Maresin 1 prevents lipopolysac-charide-induced neutrophil survival and accelerates resolu-tion of acute lung injury[J]. Shock, 2015, 44(4):371-380.
[36]	Li R, Wang Y, Zhao E, et al.Maresin 1, a proresolving lipid mediator, mitigates carbon tetrachloride-induced liver injury in mice[J]. Oxid Med Cell Longev, 2016, 2016:9203716.
[37]	Marcon R, Bento AF, Dutra RC, et al.Maresin 1, a prore-solving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis[J]. J Immunol, 2013, 191(8):4288-4298.
[38]	Hasturk H, Kantarci A, Ohira T, et al.RvE1 protects from local inflammation and osteoclast-mediated bone destruc-tion in periodontitis[J]. FASEB J, 2006, 20(2):401-413.
[39]	Serhan CN, Gotlinger K, Hong S, et al.Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing doco-satrienes[J]. J Immunol, 2006, 176(3):1848-1859.
[40]	Fredman G, Oh SF, Ayilavarapu S, et al.Impaired phagocy-tosis in localized aggressive periodontitis: rescue by Resol-vin E1[J]. PLoS ONE, 2011, 6(9):e24422.
[41]	Wang CW, Colas RA, Dalli J, et al.Maresin 1 biosynthesis and pro-resolving anti-infective functions with human loca-lized aggressive periodontitis Leukocytes[J]. Infect Immun, 2015, 84(3):658-665.
[42]	Liu D, Xu JK, Figliomeni L, et al.Expression of RANKL and OPG mRNA in periodontal disease: possible involve-ment in bone destruction[J]. Int J Mol Med, 2003, 11(1):17-21.
[43]	Shaddox LM, Wiedey J, Calderon NL, et al.Local inflam-matory markers and systemic endotoxin in aggressive perio-dontitis[J]. J Dent Res, 2011, 90(9):1140-1144.
[44]	Zwerina J, Redlich K, Schett G, et al.Pathogenesis of rheu-matoid arthritis: targeting cytokines[J]. Ann N Y Acad Sci, 2005, 10(51):716-729.
[45]	Lam RS, O’Brien-Simpson NM, Lenzo JC, et al. Macrophage depletion abates Porphyromonas gingivalis-induced alveolar bone resorption in mice[J]. J Immunol, 2014, 193(5):2349-2362
[46]	Papadopoulos G, Weinberg EO, Massari P, et al.Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss[J]. J Immunol, 2013, 190(3):1148-1157.
[47]	He D, Kou X, Luo Q, et al.Enhanced M1/M2 macrophage ratio promotes orthodontic root resorption[J]. J Dent Res, 2015, 94(1):129-139.
[48]	He D, Kou X, Yang R, et al.M1-like macrophage polariza-tion promotes orthodontic tooth movement[J]. J Dent Res, 2015, 94(9):1286-1294.
[49]	Tontonoz P, Nagy L, Alvarez JG, et al.PPARgamma pro-motes monocyte/macrophage differentiation and uptake of oxidized LDL[J]. Cell, 1998, 93(2):241-252.
[50]	Schwab JM, Chiang N, Arita M, et al.Resolvin E1 and pro-tectin D1 activate inflammation-resolution programmes[J]. Nature, 2007, 447(7146):869-874.
[51]	Hasturk H, Kantarci A, Goguet-Surmenian E, et al.Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo[J]. J Immunol, 2007, 179(10):7021-7029.
[52]	Serhan CN, Takano T, Chiang N, et al.Formation of endo-genous “antiinflammatory” lipid mediators by transcellular biosynthesis. Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability[J]. Am J Respir Crit Care Med, 2000, 161(2Pt 2):S95-S101.